Terlipressin

This classification denotes an antidiurectic hormone analogue, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7Z5X49W53P. European Medicines Agency schedules Terlipressin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10927MIG. Terlipressin generally arises in the molecular formula C52H74N16O15S2. The term TERLIPRESSIN is an International Non-Proprietary Name or INN. TERLIPRESSIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule terlipressin under HS 29371900 and SITC 54154. As of Q4 2014, TERLIPRESSIN remains the US FDA Preferred Term for this commodity. Terlipressin bears US NLM identifiers UMLS ID C0145185 and NCI Concept Code C77387. SMILES: S1SCC(NC(=O)CNC(=O)CNC(=O)CN)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2C(CCC2)C(=O)NC(CCCCN)C(=O)NCC(=O)N)C1)CC(=O)N)CCC(=O)N)CC1CCCCC1)CC1CCC(O)CC1.